Literature DB >> 20171779

Age-specific risk of incident prostate cancer and risk of death from prostate cancer defined by the number of affected family members.

Andreas Brandt1, Justo Lorenzo Bermejo, Jan Sundquist, Kari Hemminki.   

Abstract

BACKGROUND: The thorough assessment of familial prostate cancer (PCa) risk is as important as ever to provide a basis for clinical counselling and screening recommendations.
OBJECTIVE: Our aim was to determine the age-specific risks of PCa and the risk of death from PCa according to the number and the age of affected first-degree relatives. DESIGN, SETTING, AND PARTICIPANTS: The nationwide Swedish Family-Cancer Database includes a record of >11.8 million individuals and their cancers from 1958 to 2006. All men from the database with identified parents (>3.9 million individuals) were followed between 1961 and 2006. The study included 26 651 PCa patients, of whom 5623 were familial. MEASUREMENTS: The age-specific hazard ratios (HRs) of PCa and the HRs of death from PCa were calculated according to the number and age of affected fathers and brothers. RESULTS AND LIMITATIONS: The HRs of PCa diagnosis increased with the number of affected relatives and decreased with increasing age. The highest HRs were observed for men <65 yr of age with three affected brothers (HR: approximately 23) and the lowest for men between 65 and 74 yr of age with an affected father (HR: approximately 1.8). The HRs increased with decreasing paternal or fraternal diagnostic age. The pattern of the risk of death from familial PCa was similar to the incidence data.
CONCLUSIONS: The present results should guide clinical counselling and demonstrate the vast increases in risk when multiple first-degree relatives are affected. Copyright (c) 2010 European Association of Urology. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20171779     DOI: 10.1016/j.eururo.2010.02.002

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  31 in total

1.  Randomized trial finds that prostate cancer genetic risk score feedback targets prostate-specific antigen screening among at-risk men.

Authors:  Aubrey R Turner; Brian R Lane; Dan Rogers; Isaac Lipkus; Kathryn Weaver; Suzanne C Danhauer; Zheng Zhang; Fang-Chi Hsu; Sabrina L Noyes; Tamara Adams; Helga Toriello; Thomas Monroe; Trudy McKanna; Tracey Young; Ryan Rodarmer; Richard J Kahnoski; Mouafak Tourojman; A Karim Kader; S Lilly Zheng; William Baer; Jianfeng Xu
Journal:  Cancer       Date:  2016-07-19       Impact factor: 6.860

2.  Latino men and familial risk communication about prostate cancer.

Authors:  Elisabeth M Hicks; Mark S Litwin; Sally L Maliski
Journal:  Oncol Nurs Forum       Date:  2014-09       Impact factor: 2.172

Review 3.  [Familial prostate cancer and genetic predisposition].

Authors:  V H Meissner; M Jahnen; K Herkommer
Journal:  Urologe A       Date:  2021-03-15       Impact factor: 0.639

4.  Factors associated with appropriate and low-value PSA testing.

Authors:  Nathaniel Oswald; Tengda Lin; Benjamin Haaland; Michael Flynn; Kensaku Kawamoto; Kathleen A Cooney; William Lowrance; Heidi A Hanson; Brock O'Neil
Journal:  Cancer Epidemiol       Date:  2020-05-08       Impact factor: 2.984

Review 5.  Risk-based prostate cancer screening: who and how?

Authors:  Allison S Glass; K Clint Cary; Matthew R Cooperberg
Journal:  Curr Urol Rep       Date:  2013-06       Impact factor: 3.092

Review 6.  Prostate cancer epidemiology in the United States.

Authors:  Otis W Brawley
Journal:  World J Urol       Date:  2012-04-05       Impact factor: 4.226

7.  Familial risk and familial survival in prostate cancer.

Authors:  Kari Hemminki
Journal:  World J Urol       Date:  2011-11-25       Impact factor: 4.226

8.  Predicting prostate cancer many years before diagnosis: how and why?

Authors:  Andrew J Vickers; Hans Lilja
Journal:  World J Urol       Date:  2011-11-20       Impact factor: 4.226

Review 9.  Prostate cancer in young men: an important clinical entity.

Authors:  Claudia A Salinas; Alex Tsodikov; Miriam Ishak-Howard; Kathleen A Cooney
Journal:  Nat Rev Urol       Date:  2014-05-13       Impact factor: 14.432

10.  A positive family history as a risk factor for prostate cancer in a population-based study with organised prostate-specific antigen screening: results of the Swiss European Randomised Study of Screening for Prostate Cancer (ERSPC, Aarau).

Authors:  Marco Randazzo; Alexander Müller; Sigrid Carlsson; Daniel Eberli; Andreas Huber; Rainer Grobholz; Lukas Manka; Ashkan Mortezavi; Tullio Sulser; Franz Recker; Maciej Kwiatkowski
Journal:  BJU Int       Date:  2015-10-06       Impact factor: 5.588

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.